Crossmark

Effect of L-carnitine supplementation on lipid profile and apolipoproteins in children on hemodialysis: a randomized placebo-controlled clinical trial

Crossref DOI link: https://doi.org/10.1007/s00467-021-05080-1

Published Online: 2021-05-26

Published Print: 2021-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hamedi-Kalajahi, Fatemeh

Zarezadeh, Meysam

Mojtahedi, Sayed Yousef

Shabbidar, Sakineh

Fahimi, Dariyoosh

Imani, Hossein
Funding

Funding for this research was provided by:

Tehran University of Medical Sciences and Health Services
License Information

Text and Data Mining valid from 2021-05-26

Version of Record valid from 2021-05-26
More Information

Article History

Received: 11 January 2021

Revised: 26 February 2021

Accepted: 2 April 2021

First Online: 26 May 2021

Declarations

:

: This study was approved by Tehran Medical University Research Ethical Committee (IR.TUMS.VCR.REC.1397.1067).

: We declare that the study was performed according to the international, national, and institutional rules considering animal experiments, clinical studies, human and animal rights, and biodiversity rights.

: All participants in this study were informed about the objectives of the study and the side effects of the dietary supplement used in the intervention. The informed consent form for this research was approved and signed by the participants or their legal guardians at the beginning of the study. This publication has the right to request the relevant documents.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below